Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Overview of attention for article published in Gastroenterology, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 15 news outlets
twitter: 52 X users
patent: 2 patents

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 102 Mendeley

So far, Altmetric has seen 24 news stories from 15 outlets.

When to Use Direct-Acting Antivirals in Hepatocellular Carcinoma

Medical Health News, 09 Jul 2019

During the last several decades, the incidence of hepatocellular carcinoma (HCC) has risen sharply in the United States and…

Direct-Acting Antiviral Therapy and Recurrence of Hepatitis C-Related Hepatocellular Carcinoma

Medical Health News, 23 Apr 2019

Home » Topics » GI Illness » Hepatitis According to results of a retrospective cohort study of patients with hepatitis C viral (H…

Spotlight on direct-acting antivirals

Medical Health News, 22 Feb 2019

Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection are associated with higher survival rates after liver…

Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer Patients

Medicinenet, 14 Feb 2019

Latest Digestion News TUESDAY, Feb. 12, 2019 (HealthDay News) -- It's safe to use antiviral drugs to treat hepatitis C in liver…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 20 additional news stories.